<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37335611</PMID><DateRevised><Year>2023</Year><Month>07</Month><Day>14</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">1929-0748</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><PubDate><Year>2023</Year><Month>Jun</Month><Day>19</Day></PubDate></JournalIssue><Title>JMIR research protocols</Title><ISOAbbreviation>JMIR Res Protoc</ISOAbbreviation></Journal><ArticleTitle>Co-Design of a Voice-Based Digital Health Solution to Monitor Persisting Symptoms Related to COVID-19 (UpcomingVoice Study): Protocol for a Mixed Methods Study.</ArticleTitle><Pagination><StartPage>e46103</StartPage><MedlinePgn>e46103</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e46103</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.2196/46103</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Between 10% and 20% of people with a COVID-19 infection will develop the so-called long COVID syndrome, which is characterized by fluctuating symptoms. Long COVID has a high impact on the quality of life of affected people, who often feel abandoned by the health care system and are demanding new tools to help them manage their symptoms. New digital monitoring solutions could allow them to visualize the evolution of their symptoms and could be tools to communicate with health care professionals (HCPs). The use of voice and vocal biomarkers could facilitate the accurate and objective monitoring of persisting and fluctuating symptoms. However, to assess the needs and ensure acceptance of this innovative approach by its potential users-people with persisting COVID-19-related symptoms, with or without a long COVID diagnosis, and HCPs involved in long COVID care-it is crucial to include them in the entire development process.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">In the UpcomingVoice study, we aimed to define the most relevant aspects of daily life that people with long COVID would like to be improved, assess how the use of voice and vocal biomarkers could be a potential solution to help them, and determine the general specifications and specific items of a digital health solution to monitor long COVID symptoms using vocal biomarkers with its end users.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">UpcomingVoice is a cross-sectional mixed methods study and consists of a quantitative web-based survey followed by a qualitative phase based on semistructured individual interviews and focus groups. People with long COVID and HCPs in charge of patients with long COVID will be invited to participate in this fully web-based study. The quantitative data collected from the survey will be analyzed using descriptive statistics. Qualitative data from the individual interviews and the focus groups will be transcribed and analyzed using a thematic analysis approach.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The study was approved by the National Research Ethics Committee of Luxembourg (number 202208/04) in August 2022 and started in October 2022 with the launch of the web-based survey. Data collection will be completed in September 2023, and the results will be published in 2024.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This mixed methods study will identify the needs of people affected by long COVID in their daily lives and describe the main symptoms or problems that would need to be monitored and improved. We will determine how using voice and vocal biomarkers could meet these needs and codevelop a tailored voice-based digital health solution with its future end users. This project will contribute to improving the quality of life and care of people with long COVID. The potential transferability to other diseases will be explored, which will contribute to the deployment of vocal biomarkers in general.</AbstractText><AbstractText Label="TRIAL REGISTRATION" NlmCategory="BACKGROUND">ClinicalTrials.gov NCT05546918; https://clinicaltrials.gov/ct2/show/NCT05546918.</AbstractText><AbstractText Label="INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID)" NlmCategory="UNASSIGNED">DERR1-10.2196/46103.</AbstractText><CopyrightInformation>&#xa9;Aurelie Fischer, Gloria A Aguayo, Pauline Oustric, Laurent Morin, Jerome Larche, Charles Benoy, Guy Fagherazzi. Originally published in JMIR Research Protocols (https://www.researchprotocols.org), 19.06.2023.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fischer</LastName><ForeName>Aurelie</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-2822-2874</Identifier><AffiliationInfo><Affiliation>Deep Digital Phenotyping Research Unit, Department of Precision Health, Luxembourg Institute of Health, Strassen, Luxembourg.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Universit&#xe9; de Lorraine, Nancy, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aguayo</LastName><ForeName>Gloria A</ForeName><Initials>GA</Initials><Identifier Source="ORCID">0000-0002-5625-1664</Identifier><AffiliationInfo><Affiliation>Deep Digital Phenotyping Research Unit, Department of Precision Health, Luxembourg Institute of Health, Strassen, Luxembourg.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oustric</LastName><ForeName>Pauline</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0003-2004-4222</Identifier><AffiliationInfo><Affiliation>Association ApresJ20 COVID Long France, Luce, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morin</LastName><ForeName>Laurent</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-7406-4838</Identifier><AffiliationInfo><Affiliation>Association ApresJ20 COVID Long France, Luce, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Larche</LastName><ForeName>Jerome</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-3065-4828</Identifier><AffiliationInfo><Affiliation>F&#xe9;d&#xe9;ration des Acteurs de la Coordination en Sant&#xe9;-Occitanie, H&#xf4;pital La Grave, Toulouse, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Benoy</LastName><ForeName>Charles</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0003-1478-0135</Identifier><AffiliationInfo><Affiliation>Centre Hospitalier Neuro-Psychiatrique, Ettelbruck, Luxembourg.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Universit&#xe4;re Psychiatrische Kliniken Basel, Basel, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fagherazzi</LastName><ForeName>Guy</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0001-5033-5966</Identifier><AffiliationInfo><Affiliation>Deep Digital Phenotyping Research Unit, Department of Precision Health, Luxembourg Institute of Health, Strassen, Luxembourg.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT05546918</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>06</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>Canada</Country><MedlineTA>JMIR Res Protoc</MedlineTA><NlmUniqueID>101599504</NlmUniqueID><ISSNLinking>1929-0748</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">co-design</Keyword><Keyword MajorTopicYN="N">digital health</Keyword><Keyword MajorTopicYN="N">long COVID symptoms</Keyword><Keyword MajorTopicYN="N">mixed methods</Keyword><Keyword MajorTopicYN="N">mobile phone</Keyword><Keyword MajorTopicYN="N">vocal biomarkers</Keyword></KeywordList><CoiStatement>Conflicts of Interest: None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>1</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>4</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>4</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>19</Day><Hour>13</Hour><Minute>9</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>19</Day><Hour>13</Hour><Minute>8</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>19</Day><Hour>11</Hour><Minute>54</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>6</Month><Day>19</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37335611</ArticleId><ArticleId IdType="pmc">PMC10337302</ArticleId><ArticleId IdType="doi">10.2196/46103</ArticleId><ArticleId IdType="pii">v12i1e46103</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Coronavirus (COVID-19) dashboard. World Health Organization.  [2022-01-17].  
 https://covid19.who.int
.</Citation></Reference><Reference><Citation>Fagherazzi G, Fischer A, Betsou F, Vaillant M, Ernens I, Masi S, Mossong J, Staub T, Brault D, Bahlawane C, Rashid MA, Ollert M, Gantenbein M, Huiart L. Protocol for a prospective, longitudinal cohort of people with COVID-19 and their household members to study factors associated with disease severity: the Predi-COVID study. BMJ Open. 2020 Nov 23;10(11):e041834. doi: 10.1136/bmjopen-2020-041834. 
 
bmjopen-2020-041834</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2020-041834</ArticleId><ArticleId IdType="pmc">PMC7684799</ArticleId><ArticleId IdType="pubmed">33234656</ArticleId></ArticleIdList></Reference><Reference><Citation>A clinical case definition of post COVID-19 condition by a Delphi consensus, 6 October 2021. World Health Organization. 2021. Oct 6,  [2022-07-15].  
 https://www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1
.</Citation></Reference><Reference><Citation>Hastie CE, Lowe DJ, McAuley A, Winter AJ, Mills NL, Black C, Scott JT, O'Donnell CA, Blane DN, Browne S, Ibbotson TR, Pell JP. Outcomes among confirmed cases and a matched comparison group in the Long-COVID in Scotland study. Nat Commun. 2022 Oct 12;13(1):5663. doi: 10.1038/s41467-022-33415-5. doi: 10.1038/s41467-022-33415-5.10.1038/s41467-022-33415-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-33415-5</ArticleId><ArticleId IdType="doi">10.1038/s41467-022-33415-5</ArticleId><ArticleId IdType="pmc">PMC9556711</ArticleId><ArticleId IdType="pubmed">36224173</ArticleId></ArticleIdList></Reference><Reference><Citation>Ballering AV, van Zon SK, Olde Hartman TC, Rosmalen JG, Lifelines Corona Research Initiative  Persistence of somatic symptoms after COVID-19 in the Netherlands: an observational cohort study. Lancet. 2022 Aug 06;400(10350):452&#x2013;61. doi: 10.1016/S0140-6736(22)01214-4. 
 
S0140-6736(22)01214-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)01214-4</ArticleId><ArticleId IdType="pmc">PMC9352274</ArticleId><ArticleId IdType="pubmed">35934007</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubin R. As their numbers grow, COVID-19 "Long Haulers" stump experts. JAMA. 2020 Oct 13;324(14):1381&#x2013;3. doi: 10.1001/jama.2020.17709.2771111</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.17709</ArticleId><ArticleId IdType="pubmed">32965460</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischer A, Zhang L, Elb&#xe9;ji A, Wilmes P, Oustric P, Staub T, Nazarov PV, Ollert M, Fagherazzi G. Long COVID symptomatology after 12 months and its impact on quality of life according to initial coronavirus disease 2019 disease severity. Open Forum Infect Dis. 2022 Aug;9(8):ofac397. doi: 10.1093/ofid/ofac397. 
 
ofac397</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofac397</ArticleId><ArticleId IdType="pmc">PMC9379809</ArticleId><ArticleId IdType="pubmed">35983269</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah W, Hillman T, Playford ED, Hishmeh L. Managing the long term effects of covid-19: summary of NICE, SIGN, and RCGP rapid guideline. BMJ. 2021 Jan 22;372:n136. doi: 10.1136/bmj.n136.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n136</ArticleId><ArticleId IdType="pubmed">33483331</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, Assaf GS, McCorkell L, Wei H, Low RJ, Re'em Y, Redfield S, Austin JP, Akrami A. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021 Aug;38:101019. doi: 10.1016/j.eclinm.2021.101019. 
 
S2589-5370(21)00299-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Fagherazzi G, Fischer A, Ismael M, Despotovic V. Voice for health: the use of vocal biomarkers from research to clinical practice. Digit Biomark. 2021 Apr 16;5(1):78&#x2013;88. doi: 10.1159/000515346. doi: 10.1159/000515346.dib-0005-0078</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000515346</ArticleId><ArticleId IdType="doi">10.1159/000515346</ArticleId><ArticleId IdType="pmc">PMC8138221</ArticleId><ArticleId IdType="pubmed">34056518</ArticleId></ArticleIdList></Reference><Reference><Citation>Mundt JC, Vogel AP, Feltner DE, Lenderking WR. Vocal acoustic biomarkers of depression severity and treatment response. Biol Psychiatry. 2012 Oct 01;72(7):580&#x2013;7. doi: 10.1016/j.biopsych.2012.03.015. 
 
S0006-3223(12)00263-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopsych.2012.03.015</ArticleId><ArticleId IdType="pmc">PMC3409931</ArticleId><ArticleId IdType="pubmed">22541039</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamdan AI, Jabbour J, Nassar J, Dahouk I, Azar ST. Vocal characteristics in patients with type 2 diabetes mellitus. Eur Arch Otorhinolaryngol. 2012 May;269(5):1489&#x2013;95. doi: 10.1007/s00405-012-1933-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00405-012-1933-7</ArticleId><ArticleId IdType="pubmed">22302159</ArticleId></ArticleIdList></Reference><Reference><Citation>Laguarta J, Hueto F, Subirana B. COVID-19 artificial intelligence diagnosis using only cough recordings. IEEE Open J Eng Med Biol. 2020 Sep 29;1:275&#x2013;81. doi: 10.1109/OJEMB.2020.3026928. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1109/OJEMB.2020.3026928</ArticleId><ArticleId IdType="pmc">PMC8545024</ArticleId><ArticleId IdType="pubmed">34812418</ArticleId></ArticleIdList></Reference><Reference><Citation>Pahar M, Klopper M, Warren R, Niesler T. COVID-19 detection in cough, breath and speech using deep transfer learning and bottleneck features. Comput Biol Med. 2022 Feb;141:105153. doi: 10.1016/j.compbiomed.2021.105153. 
 
S0010-4825(21)00947-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.compbiomed.2021.105153</ArticleId><ArticleId IdType="pmc">PMC8679499</ArticleId><ArticleId IdType="pubmed">34954610</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown C, Chauhan J, Grammenos A, Han J, Hasthanasombat A, Spathis D, Xia T, Cicuta P, Mascolo C. Exploring automatic diagnosis of COVID-19 from crowdsourced respiratory sound data. Proceedings of the 26th ACM SIGKDD International Conference on Knowledge Discovery &amp; Data Mining; KDD '20; July 6-10, 2020; Virtual Event. 2020. Aug, pp. 3474&#x2013;84.</Citation><ArticleIdList><ArticleId IdType="doi">10.1145/3394486.3412865</ArticleId></ArticleIdList></Reference><Reference><Citation>Maor E, Tsur N, Barkai G, Meister I, Makmel S, Friedman E, Aronovich D, Mevorach D, Lerman A, Zimlichman E, Bachar G. Noninvasive vocal biomarker is associated with severe acute respiratory syndrome coronavirus 2 infection. Mayo Clin Proc Innov Qual Outcomes. 2021 Jun;5(3):654&#x2013;62. doi: 10.1016/j.mayocpiqo.2021.05.007. 
 
S2542-4548(21)00074-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocpiqo.2021.05.007</ArticleId><ArticleId IdType="pmc">PMC8120447</ArticleId><ArticleId IdType="pubmed">34007956</ArticleId></ArticleIdList></Reference><Reference><Citation>Asiaee M, Vahedian-Azimi A, Atashi SS, Keramatfar A, Nourbakhsh M. Voice quality evaluation in patients with COVID-19: an acoustic analysis. J Voice. 2022 Nov;36(6):879.e13&#x2013;9. doi: 10.1016/j.jvoice.2020.09.024. 
 
S0892-1997(20)30368-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jvoice.2020.09.024</ArticleId><ArticleId IdType="pmc">PMC7528943</ArticleId><ArticleId IdType="pubmed">33051108</ArticleId></ArticleIdList></Reference><Reference><Citation>Dassie-Leite AP, Gueths TP, Ribeiro VV, Pereira EC, Martins PD, Daniel CR. Vocal signs and symptoms related to COVID-19 and risk factors for their persistence. J Voice (forthcoming) 2021 Aug 11; doi: 10.1016/j.jvoice.2021.07.013. 
 
S0892-1997(21)00253-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jvoice.2021.07.013</ArticleId><ArticleId IdType="pmc">PMC8354794</ArticleId><ArticleId IdType="pubmed">34583881</ArticleId></ArticleIdList></Reference><Reference><Citation>Tohidast SA, Mansuri B, Memarian M, Ghobakhloo AH, Scherer RC. Voice quality and vocal tract discomfort symptoms in patients with COVID-19. J Voice (forthcoming) 2021 Oct 13; doi: 10.1016/j.jvoice.2021.09.039. 
 
S0892-1997(21)00334-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jvoice.2021.09.039</ArticleId><ArticleId IdType="pmc">PMC8511652</ArticleId><ArticleId IdType="pubmed">34776316</ArticleId></ArticleIdList></Reference><Reference><Citation>Elb&#xe9;ji A, Zhang L, Higa E, Fischer A, Despotovic V, Nazarov PV, Aguayo G, Fagherazzi G. Vocal biomarker predicts fatigue in people with COVID-19: results from the prospective Predi-COVID cohort study. BMJ Open. 2022 Nov 22;12(11):e062463. doi: 10.1136/bmjopen-2022-062463. 
 
bmjopen-2022-062463</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2022-062463</ArticleId><ArticleId IdType="pmc">PMC9684280</ArticleId><ArticleId IdType="pubmed">36414294</ArticleId></ArticleIdList></Reference><Reference><Citation>Higa E, Elb&#xe9;ji A, Zhang L, Fischer A, Aguayo GA, Nazarov PV, Fagherazzi G. Discovery and analytical validation of a vocal biomarker to monitor anosmia and ageusia in patients with COVID-19: cross-sectional study. JMIR Med Inform. 2022 Nov 08;10(11):e35622. doi: 10.2196/35622. 
 
v10i11e35622</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/35622</ArticleId><ArticleId IdType="pmc">PMC9645416</ArticleId><ArticleId IdType="pubmed">36265042</ArticleId></ArticleIdList></Reference><Reference><Citation>Fagherazzi G, Zhang L, Elb&#xe9;ji A, Higa E, Despotovic V, Ollert M, Aguayo GA, Nazarov PV, Fischer A. A voice-based biomarker for monitoring symptom resolution in adults with COVID-19: findings from the prospective Predi-COVID cohort study. PLOS Digit Health. 2022 Oct;1(10):e0000112. doi: 10.1371/journal.pdig.0000112. 
 
PDIG-D-21-00115</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pdig.0000112</ArticleId><ArticleId IdType="pmc">PMC9931359</ArticleId><ArticleId IdType="pubmed">36812535</ArticleId></ArticleIdList></Reference><Reference><Citation>S&#xf8;holm U, Broadley M, Zaremba N, Divilly P, Nefs G, Mahmoudi Z, de Galan B, Pedersen-Bjergaard U, Brennan A, Pollard DJ, McCrimmon RJ, A Amiel S, Hendrieckx C, Speight J, Choudhary P, Pouwer F, Hypo-RESOLVE Consortium  Investigating the day-to-day impact of hypoglycaemia in adults with type 1 or type 2 diabetes: design and validation protocol of the Hypo-METRICS application. BMJ Open. 2022 Feb 01;12(2):e051651. doi: 10.1136/bmjopen-2021-051651. 
 
bmjopen-2021-051651</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2021-051651</ArticleId><ArticleId IdType="pmc">PMC8808414</ArticleId><ArticleId IdType="pubmed">35105572</ArticleId></ArticleIdList></Reference><Reference><Citation>Morton S, Fitzsimons C, Jepson R, Saunders DH, Sivaramakrishnan D, Niven A. What works to reduce sedentary behavior in the office, and could these intervention components transfer to the home working environment?: a rapid review and transferability appraisal. Front Sports Act Living. 2022 Jul 29;4:954639. doi: 10.3389/fspor.2022.954639. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fspor.2022.954639</ArticleId><ArticleId IdType="pmc">PMC9372484</ArticleId><ArticleId IdType="pubmed">35966113</ArticleId></ArticleIdList></Reference><Reference><Citation>Goeree R, He J, O'Reilly D, Tarride JE, Xie F, Lim M, Burke N. Transferability of health technology assessments and economic evaluations: a systematic review of approaches for assessment and application. Clinicoecon Outcomes Res. 2011;3:89&#x2013;104. doi: 10.2147/CEOR.S14404. 
 
ceor-3-089</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/CEOR.S14404</ArticleId><ArticleId IdType="pmc">PMC3169976</ArticleId><ArticleId IdType="pubmed">21935337</ArticleId></ArticleIdList></Reference><Reference><Citation>Stoyanov SR, Hides L, Kavanagh DJ, Wilson H. Development and validation of the user version of the Mobile Application Rating Scale (uMARS) JMIR Mhealth Uhealth. 2016 Jun 10;4(2):e72. doi: 10.2196/mhealth.5849. 
 
v4i2e72</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/mhealth.5849</ArticleId><ArticleId IdType="pmc">PMC4920963</ArticleId><ArticleId IdType="pubmed">27287964</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris PA, Taylor R, Minor BL, Elliott V, Fernandez M, O'Neal L, McLeod L, Delacqua G, Delacqua F, Kirby J, Duda SN, REDCap Consortium  The REDCap consortium: building an international community of software platform partners. J Biomed Inform. 2019 Jul;95:103208. doi: 10.1016/j.jbi.2019.103208. 
 
S1532-0464(19)30126-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2019.103208</ArticleId><ArticleId IdType="pmc">PMC7254481</ArticleId><ArticleId IdType="pubmed">31078660</ArticleId></ArticleIdList></Reference><Reference><Citation>How to involve people in research. INVOLVE, National Institute for Health Research.  [2022-04-05].  
 https://www.invo.org.uk/find-out-more/how-to-involve-people/
</Citation></Reference><Reference><Citation>Manta C, Patrick-Lake B, Goldsack JC. Digital measures that matter to patients: a framework to guide the selection and development of digital measures of health. Digit Biomark. 2020 Sep 15;4(3):69&#x2013;77. doi: 10.1159/000509725. doi: 10.1159/000509725.dib-0004-0069</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000509725</ArticleId><ArticleId IdType="doi">10.1159/000509725</ArticleId><ArticleId IdType="pmc">PMC7548919</ArticleId><ArticleId IdType="pubmed">33083687</ArticleId></ArticleIdList></Reference><Reference><Citation>Sargeant J. Qualitative research part II: participants, analysis, and quality assurance. J Grad Med Educ. 2012 Mar;4(1):1&#x2013;3. doi: 10.4300/JGME-D-11-00307.1. 
 
JGME-D-11-00307</Citation><ArticleIdList><ArticleId IdType="doi">10.4300/JGME-D-11-00307.1</ArticleId><ArticleId IdType="pmc">PMC3312514</ArticleId><ArticleId IdType="pubmed">23451297</ArticleId></ArticleIdList></Reference><Reference><Citation>Moc&#x103;na&#x219;u DR. Determining the sample size in qualitative research. Int Multidisc Scientific Conf Dialog Sci Arts Relig Educ. 2020;4:181&#x2013;7. doi: 10.26520/mcdsare.2020.4.181-187. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.26520/mcdsare.2020.4.181-187</ArticleId></ArticleIdList></Reference><Reference><Citation>Creswell JW. A Concise Introduction to Mixed Methods Research. Thousand Oaks, CA, USA: Sage Publications; 2014.</Citation></Reference><Reference><Citation>Saunders B, Sim J, Kingstone T, Baker S, Waterfield J, Bartlam B, Burroughs H, Jinks C. Saturation in qualitative research: exploring its conceptualization and operationalization. Qual Quant. 2018;52(4):1893&#x2013;907. doi: 10.1007/s11135-017-0574-8. 
 
574</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11135-017-0574-8</ArticleId><ArticleId IdType="pmc">PMC5993836</ArticleId><ArticleId IdType="pubmed">29937585</ArticleId></ArticleIdList></Reference><Reference><Citation>Hennink M, Kaiser BN. Sample sizes for saturation in qualitative research: a systematic review of empirical tests. Soc Sci Med. 2022 Jan;292:114523. doi: 10.1016/j.socscimed.2021.114523. 
 
S0277-9536(21)00855-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.socscimed.2021.114523</ArticleId><ArticleId IdType="pubmed">34785096</ArticleId></ArticleIdList></Reference><Reference><Citation>Krueger RA, Casey MA. Participants in a focus group. In: Krueger RA, Casey MA, editors. Focus Groups: A Practical Guide for Applied Research. Thousand Oaks, CA, USA: Sage Publications; 2009.</Citation></Reference><Reference><Citation>Castleberry A, Nolen A. Thematic analysis of qualitative research data: is it as easy as it sounds? Curr Pharm Teach Learn. 2018 Jun;10(6):807&#x2013;15. doi: 10.1016/j.cptl.2018.03.019.S1877-1297(17)30060-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cptl.2018.03.019</ArticleId><ArticleId IdType="pubmed">30025784</ArticleId></ArticleIdList></Reference><Reference><Citation>Chun Tie Y, Birks M, Francis K. Grounded theory research: a design framework for novice researchers. SAGE Open Med. 2019;7:2050312118822927. doi: 10.1177/2050312118822927. 
 
10.1177_2050312118822927</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2050312118822927?url_ver=Z39.88-2003&amp;rfr_id=ori:rid:crossref.org&amp;rfr_dat=cr_pub0pubmed</ArticleId><ArticleId IdType="doi">10.1177/2050312118822927</ArticleId><ArticleId IdType="pmc">PMC6318722</ArticleId><ArticleId IdType="pubmed">30637106</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xed;&#x161;ka D, Liptakov&#xe1; E, Babi&#x10d;ov&#xe1; A, Batalik L, Ba&#x148;&#xe1;rov&#xe1; PS, Dobrodenkov&#xe1; S. What is the quality of life in patients with long COVID compared to a healthy control group? Front Public Health. 2022 Nov 2;10:975992. doi: 10.3389/fpubh.2022.975992. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2022.975992</ArticleId><ArticleId IdType="pmc">PMC9667067</ArticleId><ArticleId IdType="pubmed">36408018</ArticleId></ArticleIdList></Reference><Reference><Citation>Tarazona V, Kirouchena D, Clerc P, Pinsard-Laventure F, Bourrion B. Quality of life in COVID-19 outpatients: a long-term follow-up study. J Clin Med. 2022 Oct 31;11(21):6478. doi: 10.3390/jcm11216478. 
 
jcm11216478</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11216478</ArticleId><ArticleId IdType="pmc">PMC9657247</ArticleId><ArticleId IdType="pubmed">36362706</ArticleId></ArticleIdList></Reference><Reference><Citation>Parker M, Sawant HB, Flannery T, Tarrant R, Shardha J, Bannister R, Ross D, Halpin S, Greenwood DC, Sivan M. Effect of using a structured pacing protocol on post-exertional symptom exacerbation and health status in a longitudinal cohort with the post-COVID-19 syndrome. J Med Virol. 2023 Jan;95(1):e28373. doi: 10.1002/jmv.28373. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.28373</ArticleId><ArticleId IdType="pmc">PMC9878088</ArticleId><ArticleId IdType="pubmed">36461167</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischer A, Elbeji A, Aguayo G, Fagherazzi G. Recommendations for successful implementation of the use of vocal biomarkers for remote monitoring of COVID-19 and Long COVID in clinical practice and research. Interact J Med Res. 2022 Nov 15;11(2):e40655. doi: 10.2196/40655. 
 
v11i2e40655</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/40655</ArticleId><ArticleId IdType="pmc">PMC9668331</ArticleId><ArticleId IdType="pubmed">36378504</ArticleId></ArticleIdList></Reference><Reference><Citation>Xue C, Karjadi C, Paschalidis I, Au R, Kolachalama VB. Detection of dementia on voice recordings using deep learning: a Framingham heart study. Alzheimers Res Ther. 2021 Aug 31;13(1):146. doi: 10.1186/s13195-021-00888-3. 
 
10.1186/s13195-021-00888-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13195-021-00888-3</ArticleId><ArticleId IdType="doi">10.1186/s13195-021-00888-3</ArticleId><ArticleId IdType="pmc">PMC8409004</ArticleId><ArticleId IdType="pubmed">34465384</ArticleId></ArticleIdList></Reference><Reference><Citation>Hecker P, Steckhan N, Eyben F, Schuller BW, Arnrich B. Voice analysis for neurological disorder recognition-a systematic review and perspective on emerging trends. Front Digit Health. 2022 Jul 7;4:842301. doi: 10.3389/fdgth.2022.842301. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fdgth.2022.842301</ArticleId><ArticleId IdType="pmc">PMC9309252</ArticleId><ArticleId IdType="pubmed">35899034</ArticleId></ArticleIdList></Reference><Reference><Citation>The Predi-COVID study. Research Luxembourg.  [2023-05-26].  
 https://sites.lih.lu/the-predi-covid-study/about-us/project-team/
</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>